Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trans-nasal Endoscopy for Bariatric Patients

NCT: NCT06200961 · RECRUITING

NCT IDNCT06200961
StatusRECRUITING
Start Date2026-04-20
Completion2028-06
SponsorChristopher C. Thompson, MD, MSc (OTHER)
First posted
Last updated

Brief Summary

This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.

Frequently Asked Questions

What is Trans-nasal Endoscopy for Bariatric Patients?

Trans-nasal Endoscopy for Bariatric Patients is a clinical trial registered under NCT06200961. Current status: RECRUITING.

What is the status of NCT06200961?

The current status of NCT06200961 (Trans-nasal Endoscopy for Bariatric Patients) is: RECRUITING.

When did Trans-nasal Endoscopy for Bariatric Patients start?

Trans-nasal Endoscopy for Bariatric Patients started on 2026-04-20.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.